(Circulation. 1995;92:228-232.)
© 1995 American Heart Association, Inc.
Articles |
From the National Cardiovascular Center (H.U., T.Y., Y.K., K.O., T.K.), Suita, Osaka, Japan, and the National Heart and Lung Institute (H.U., R.H.A.), London, UK.
Correspondence to Hideki Uemura, MD, Department of Cardiovascular Surgery, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565, Japan.
| Abstract |
|---|
|
|
|---|
Methods and Results Twenty-seven patients considered unsuitable for a Fontan-type procedure underwent a bidirectional Glenn procedure in the presence of forward flow from the ventricles to the pulmonary arteries, the flow being maintained through the pulmonary trunk in 22 or a systemic-to-pulmonary shunt in 5. There was one surgical death due to atrioventricular valvular regurgitation. Subsequently, 9 patients have successfully undergone a total cavopulmonary connection 2.6±1.9 years after the initial procedure. Preoperative and postoperative catheterizations revealed changes in arterial oxygen saturation (75±11% compared with 83±7%, P<.001) and end-diastolic volumes of the systemic ventricles (from 238±92% to 188±97% of the expected normal volume, P<.01), whereas no difference was detected in the mean cross-sectional area of the right and left pulmonary arteries compared with the expected normal value for the right pulmonary artery (from 76±21% to 81±20%) or in the ventricular ejection fraction (from 53±8% to 50±14%). The relative regression or growth of the pulmonary arterial size was statistically related to the size of the channel for forward flow.
Conclusions Maintenance of forward flow from the ventricle provides a feasible means, when performing a bidirectional Glenn procedure, of protecting against regression of pulmonary arterial size as well as off-loading the ventricles and improving arterial oxygen saturation.
Key Words: Glenn procedure Fontan procedure surgery pulmonary arteries heart defects, congenital
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
|
Surgical Methods
The operation was performed at the age of
0.8 to 22.3 years
(mean age, 6.2±5.2 years). The calculated body surface area ranged
from 0.40 to 1.55 m2 (mean, 0.73±0.32 m2). A
bidirectional cavopulmonary anastomosis was constructed
under cardiopulmonary bypass in 21 patients, and temporary bypass
between the superior caval vein and the right atrium was used to
achieve this procedure in the other 6 patients. Plasty of the
atrioventricular valve and repair of totally anomalous
pulmonary venous connection were concomitantly achieved in 12
and 5 patients, respectively. Forward flow from the ventricles to the
pulmonary arteries was maintained through the pulmonary
trunk in 22 and via a systemic-to-pulmonary shunt in 5,
the side of the shunt being on the opposite side of the
cavopulmonary anastomosis in 4 and on the same side in 1.
Either banding of the pulmonary trunk (in 13 patients) or
pulmonary valvotomy (in 2) was added as necessary to regulate
the amount of the flow through the pulmonary trunk. The most
narrow pathway provided for forward flow to continue from the
ventricles to the pulmonary arteries was shown, based on
measurements at postoperative angiography, to range from 1.5 to 10 mm
(mean, 6.0±2.4 mm) internal diameter. This restriction was defined, on
the anteroposterior and the lateral projections during
systolic phases, as the smallest diameter at either the
subpulmonary, pulmonary annular, or
pulmonary truncal levels being produced by native
stenosis or adjusted by surgical means. In patients in whom a
systemic-to-pulmonary shunt was left open, the
previously constructed prosthetic graft was a single-woven
Dacron (Golaski) or expanded
polytetrafluoroethylene (Gore-Tex) tube 5
mm in diameter.
Postoperative Evaluation
To investigate the efficacy of this
modified option, we
analyzed data derived from preoperative (27) and postoperative
(18) catheterizations in addition to assessing clinical
prognoses. The postoperative examinations were carried out at 9.9±7.3
months (range, 1 to 22 months) after the bidirectional Glenn procedure.
In the patients undergoing a subsequent total cavopulmonary
connection (see later), these postoperative examinations were made
before the definitive surgery. The end-diastolic volume
of the systemic ventricle was described as a percentage compared with
the anticipated normal value calculated from body surface
area.11 The pulmonary arterial size
was quantified by calculating a pulmonary arterial
area index in which the mean cross-sectional area of the right and
left pulmonary arteries was compared with the anticipated
normal value for the right pulmonary
artery.12 13
Some comparable data were available for comparison from 4 patients undergoing bidirectional cavopulmonary anastomosis without construction of additional blood supply to the pulmonary arteries, the operations that were being performed before 1988.
| Results |
|---|
|
|
|---|
|
Preoperative and postoperative catheterization
revealed changes in arterial oxygen saturation (75±11%
compared with 83±7%, P<.001 by paired t test)
and end-diastolic volume of the systemic ventricles
(238±92% compared with 188±97% of the expected normal value,
P<.01, paired t test), whereas no difference was
detected in the standardized pulmonary size (76±21% and
81±20% for the pulmonary arterial area index) or
in ventricular ejection fraction (53±8% and 50±14%)
(Fig 1
). Relative regression of the pulmonary
arterial sizes tends to be minimized when the channel for
maintained forward flow is greater (Fig 2
).
Postoperative pressures within the superior caval vein or the
pulmonary arteries ranged from 8 to 18 mm Hg (mean, 11.7±3.3
mm Hg), the values being unrelated to the narrowest internal diameter
for forward flow from the ventricles to the pulmonary
arteries (Fig 2
). No correlation was detected between
end-diastolic volumes of the ventricle and the diameter
of the channel for forward flow, but recurrent
atrioventricular valvular
regurgitation appeared to significantly affect the
value of end-diastolic volume (Fig 2
). There also was
no significant difference in either the pattern of the channel for
forward flow or the side on which the shunt was left open.
|
|
| Discussion |
|---|
|
|
|---|
|
Our study illustrated that the pulmonary arterial
area index of our patients, which is a standardized indicator of
pulmonary arterial size, did not decrease as a
whole; in 12 patients, it increased (Fig 2
). If adequate growth
of the
pulmonary arterial size is to be achieved, a
significant channel is needed for forward flow. In addition to the
effect of an adequate amount of pulmonary flow, two
supplemental contributions can be considered. The first is the presence
of pulsatile flow within the pulmonary arteries. It has been
suggested that such pulsatile patterns might also be instrumental in
promoting the growth of the pulmonary arterial
tree. Such pulsatile flow could protect against the development of
pulmonary arteriovenous fistulas. As has been discussed, the
contribution of pulsatile flow, and even its existence, remains
controversial.21 22 23 In our series,
however, the pulsatile
nature of flow was unequivocally demonstrated by angiography and
Doppler echocardiography in several patients
who had a relatively large channel constructed for forward flow. The
second benefit is based on avoidance of the potential deleterious
effect on the pulmonary vasculature of exclusion of blood
draining from the liver.24 Although further biochemical or
pharmacological investigations are obviously necessary on this
subjectthe still unknown "hepatic factors"we believe
that
the additional forward flow also provides a circulation in which part
of the hepatic venous effluent joins the pulmonary
arterial perfusate. In this respect, it could be
noteworthy that so far, no pulmonary arteriovenous fistulas
have been recognized in our patients.
In contrast, the surgeon must be aware of potentially deleterious
aspects of this option. The forward flow joining the pulmonary
perfusion might be the cause of insufficient reduction of the volume
overload to the ventricles (Fig 3
). This, of course, will
depend on the
amount of the supplemental flow. When postoperative
atrioventricular valvular
regurgitation is no more than mild, the greater sizes
of the channel are not related to an excessively large
end-diastolic volume. We should consider, nevertheless,
that postoperative recurrence of
atrioventricular valvular
regurgitation can be associated with an insufficient
reduction of volume overload to the ventricle. The preoperative
end-diastolic volume of the ventricle was more than
240% of the expected normal values in 14 patients. Among these 14,
concomitant valvular surgery was necessary for treating
significant atrioventricular valvular
regurgitation in 10 (Fig 1
). Postoperative
recurrence of regurgitation occurred in 7 of
these 10 patients (5 with isomeric right appendages and 2 with usual
atrial arrangement). This compounding factor was related to death in
either the short or the long term in 5 patients. That is, a finding of
more than 240% of end-diastolic volume in patients
necessitating surgery to the regurgitant
atrioventricular valve was an unequivocal risk factor.
In such circumstances, any amount of additional pulmonary flow
could become excessive in terms of avoiding recurrent insufficiency and
obtaining adequate volume reduction. Much more restricted
channels for forward flow may well have been suitable in those patients
whose deaths were related to recurrence of
regurgitation across the
atrioventricular valve. Its significance would be
particularly greater when treating patients with a common
atrioventricular valve associated with isomeric atrial
appendages ("visceral heterotaxy").7 25
Another possible problem associated with the presence of additional flow is the increased postoperative pressure within the pulmonary arteries,14 this being equal to that within the superior caval vein. (This fact was emphasized by Dr Roger B.B. Mee (Cleveland, Ohio) during discussion at the Cardiology in the Young Symposium held at the Great Ormond Street Hospital for Sick Children, London, UK, in April 1994.) In our series, pressures within the superior caval vein were considered to be within a reasonable range. Furthermore, pressure studies during the operation in several patients revealed no significant differences between superior caval venous pressures with the forward flow open as designed and those with the flow temporarily closed. If patients had critically high pulmonary resistances, however, such an additional amount passing through the optional pathway would have been recognized as excessive as it would have induced the rise in systemic venous pressure in the upper body.
The obvious limitation of the present study is its lack of a control group. We used this option in a consecutive series of patients. Because of this, we cannot conclude whether the additional flow is advantageous for either clinical prognosis or further definitive repair. The indications for this surgical strategy of providing and regulating the forward flow, therefore, have yet to be clarified. In another respect, this also reflects the complicated initial clinical condition, as the patients had significant risk factors that ruled out an immediate definitive repair. The results of the present study showed, as a whole, that the presence of the additional flow prevented regression of pulmonary arterial size as well as off-loading the ventricle and improving arterial oxygen saturation. Excessive additional flow, however, can negate the benefits sought from partial bypass of the right heart, particularly in the setting of severe regurgitation across the atrioventricular valve. If constructed, therefore, the size of the channel for forward flow is crucial. This size must be determined on the basis of its beneficial and deleterious aspects in each individual patient.
| References |
|---|
|
|
|---|
2. Hopkins RA, Armstrong BE, Serwer GA, Peterson RJ, Oldham HN Jr. Physiological rationale for a bidirectional cavopulmonary shunt: a versatile complement to the Fontan principle. J Thorac Cardiovasc Surg. 1985;90:391-398. [Abstract]
3. Mazzera E, Corno A, Picardo S, Di Donato R, Marino B, Costa D, Marcelletti C. Bidirectional cavopulmonary shunts: clinical applications as staged or definitive palliation. Ann Thorac Surg. 1989;47:415-420. [Abstract]
4. Di Donato R, DiCarlo DC, Giannico S, Marcelletti C. Palliation of complex cardiac anomalies with subaortic obstruction: new operative approach. J Am Coll Cardiol. 1989;13:406-412. [Abstract]
5. Bridges ND, Jonas RA, Mayer JE, Flanagan MF, Keane JF, Castaneda AR. Bidirectional cavopulmonary anastomosis as interim palliation for high-risk Fontan candidates: early results. Circulation. 1990;82(suppl IV):IV-170-IV-176.
6. Douville EC, Sade RM, Fyfe DA. Hemi-Fontan operation in surgery for single ventricle: a preliminary report. Ann Thorac Surg. 1991;51:893-900. [Abstract]
7. Albanese SB, Carotti A, Di Donato RM, Mazzera E, Troconis CJ, Giannico S, Picardo S, Marcelletti C. Bidirectional cavopulmonary anastomosis in patients under two years of age. J Thorac Cardiovasc Surg. 1992;104:904-909. [Abstract]
8.
Kirklin JW, Bargeron LM, Pacifico AD. The
enlargement of small pulmonary arteries by preliminary
palliative operations. Circulation. 1977;56:612-617.
9. Nakata S, Imai Y, Takanashi Y, Kurosawa H, Tezuka K, Nakazawa M, Ando M, Takao A. A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart disease with decreased pulmonary blood flow. J Thorac Cardiovasc Surg. 1984;88:610-619. [Abstract]
10.
Mendelsohn AM, Bove EL, Lupinetti FM, Crowley DC, Lloyd
TR, Beekman RH. Central pulmonary artery growth patterns
after the bidirectional Glenn procedure. J
Thorac Cardiovasc Surg. 1994;107:1284-1290.
11. Kishimoto H, Hirose H, Nakano S, Matsuda H, Shimazaki Y, Kobayashi J, Ogawa M, Morimoto S, Arisawa J, Kawashima Y. Angiographic determination of right and left ventricular volumes and diameter of atrioventricular and semilunar valve rings in normal subjects. Shinzo. 1985;17:711-716 (in Japanese).
12. Hernandez FA, Castellanos A. The size of the main pulmonary artery in congenital heart disease. Acta Cardiol. 1966;21:1-19. [Medline] [Order article via Infotrieve]
13. Naito Y, Fujita T, Manabe H, Kawashima Y. The criteria for reconstruction of right ventricular outflow tract in total correction of tetralogy of Fallot. J Thorac Cardiovasc Surg. 1980;80:574-581. [Abstract]
14. Kobayashi J, Matsuda H, Nakano S, Shimazaki Y, Ikawa S, Mitsuno M, Takahashi Y, Kawashima Y, Arisawa J, Matsushita T. Hemodynamic effects of bidirectional cavopulmonary shunt with pulsatile pulmonary flow. Circulation. 1991;84(suppl III):III-219-III-225.
15. Triedman JK, Bridges ND, Mayer JE, Lock JE. Prevalence and risk factors for aortopulmonary collateral vessels after Fontan and bidirectional Glenn procedures. J Am Coll Cardiol. 1993;22:207-215. [Abstract]
16.
Ichikawa H, Yagihara T, Kishimoto H, Isobe F, Yamamoto
F, Nishigaki K, Matsuki O, Fujita T. Extent of
aortopulmonary collateral blood flow as a risk factor for
Fontan operations. Ann Thorac Surg. 1995;59:433-437.
17. Matsuki O, Yagihara T, Kawashima Y. A new surgical approach for preparation of candidates for the Fontan operation with acquired systemic-pulmonary collateral arteries. Cardiol Young. 1995;5:122-124.
18. Yagihara T, Kishimoto H, Isobe F, Yamamoto F, Nishigaki K, Uemura H, Kawashima Y. Indication and result of right heart bypass. Jpn J Cardiovasc Surg. 1991;20:1389-1392.
19. Kirklin JW, Barratt-Boyes BG. Tricuspid atresia and the Fontan operation. In: Kirklin JW, Barratt-Boyes BG, eds. Cardiac Surgery, 2nd ed, vol 2. New York, NY: Churchill Livingstone Inc; 1993:1065-1104.
20. Fontan F, Fernandez G, Costa F, Naftel DC, Tritto F, Blackstone EH, Kirklin JW. The size of the pulmonary arteries and the results of the Fontan operation. J Thorac Cardiovasc Surg. 1989;98:711-724. [Abstract]
21.
Cloutier A, Ash JM, Smallhorn JF, Williams WG, Trusler
GA, Rowe RD, Rabinobitch M. Abnormal distribution of
pulmonary blood flow after the Glenn shunt or Fontan procedure:
risk factor of development of arteriovenous fistulae.
Circulation. 1985;72:471-479.
22.
Nakazawa M, Nojima K, Okuda H, Imai Y, Nakanishi T,
Kurosawa H, Takao A. Flow dynamics in the main pulmonary
artery after the Fontan procedure in patients with tricuspid atresia or
single ventricle. Circulation. 1987;75:1117-1123.
23.
Redington AN, Penny D, Shinebourne EA.
Pulmonary blood flow after total
cavopulmonary shunt. Br Heart J. 1991;65:213-217.
24.
Feuerstein IM, Martin P, Simon TR.
Hypoxia and cyanosis in alpha-1-antitrypsin deficiency:
cirrhosis as an unusual etiologic factor. Chest. 1991;100:1323-1327.
25. Humes RA, Feldt RH, Porter CJ, Julsrud PR, Puga FJ, Danielson GK. The modified Fontan operation for asplenia and polysplenia syndrome. J Thorac Cardiovasc Surg. 1988;96:212-218.[Abstract]
This article has been cited by other articles:
![]() |
D. F. Calvaruso, A. Rubino, S. Ocello, N. Salviato, D. Guardi, D. F. Petruccelli, A. Cipriani, K. Fattouch, S. Agati, C. Mignosa, et al. Bidirectional Glenn and Antegrade Pulmonary Blood Flow: Temporary or Definitive Palliation? Ann. Thorac. Surg., April 1, 2008; 85(4): 1389 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshida, M. Yamaguchi, N. Yoshimura, H. Murakami, H. Matsuhisa, and Y. Okita Appropriate Additional Pulmonary Blood Flow at the Bidirectional Glenn Procedure is Useful for Completion of Total Cavopulmonary Connection Ann. Thorac. Surg., September 1, 2005; 80(3): 976 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shiraishi, H. Uemura, K. Kagisaki, M. Koh, T. Yagihara, and S. Kitamura The Off-Pump Fontan Procedure by Simply Cross-Clamping the Inferior Caval Vein Ann. Thorac. Surg., June 1, 2005; 79(6): 2083 - 2088. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. McElhinney, S. M. Marianeschi, and V. M. Reddy Additional pulmonary blood flow with the bidirectional Glenn anastomosis: does it make a difference? Ann. Thorac. Surg., August 1, 1998; 66(2): 668 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, R. S. McLeod, D. A. Gordon, and Z. Yao The Microsomal Triglyceride Transfer Protein Facilitates Assembly and Secretion of Apolipoprotein B-containing Lipoproteins and Decreases Cotranslational Degradation of Apolipoprotein B in Transfected COS-7 Cells J. Biol. Chem., June 14, 1996; 271(24): 14124 - 14133. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |